iCAD, R2 tangle over patents

iCAD Inc. recently announced that it received a letter from competitor R2 Technology, Inc. advising them of R2's position that iCAD's Second Look product lines allegedly infringed on US Patents 6,266,435, 6,477,262 and 6,574,357, which are licensed to R2, according to a release.

In a September 2003 settlement agreement that resolved some patent infringement litigation between the companies, these patents were created as continuations in part of the patents already licensed to iCAD by R2.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.